Evidence map›Paper›PMID 19834793›Full record

ArticleJournal of clinical immunology2010

IgA deficiency and the MHC: assessment of relative risk and microheterogeneity within the HLA A1 B8, DR3 (8.1) haplotype.

Javad Mohammadi, Ryan Ramanujam, Sara Jarefors, Nima Rezaei, Asghar Aghamohammadi, Peter K Gregersen, Lennart Hammarström

Open access · greenAbstract read
In one paragraph

Article in Journal of clinical immunology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Article
  6. Clinical manifestation for immunoglobulin A deficiency: a systematic review and meta-analysis.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2023
    Review
  7. Autoimmunity in Primary Immunodeficiencies (PID).Clinical reviews in allergy & immunology · 2023
    Review
  8. Review
  9. Review
  10. Innate Mechanisms in Selective IgA Deficiency.Frontiers in immunology · 2021
    Review
  11. Review
  12. Endocrinopathies in Inborn Errors of Immunity.Frontiers in immunology · 2021
    Review
  13. Review
  14. Article
  15. The clinical implications of selective IgA deficiency.Journal of translational autoimmunity · 2019
    Review
  16. Article
  17. Review
  18. An Expanded Role for HLA Genes:Frontiers in immunology · 2017
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 3 countries.

Javad MohammadiDivision of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital Huddinge, Stockholm, Sweden.
Ryan Ramanujam
Sara Jarefors
Nima Rezaei
Asghar Aghamohammadi
Peter K Gregersen
Lennart Hammarström
Karolinska Institutet · SEKarolinska University Hospital · SEChildren's Medical Center · IRFeinstein Institute for Medical Research · USTehran University of Medical Sciences · IR

Funding

Systemic Lupus Erythematosus and Ulcerative Colitis StudyU19AI067152 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAMMARSTROM, LENNART · 2005 to 2009
$10.1M
Mapping Autoimmune Phenotypes in Multiplex FamiliesR01AI068759 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI GREGERSEN, PETER K. · 2007 to 2011
$4.7M
NIAID NIH HHS R01 AI068759NIAID NIH HHS U19 AI067152NIAID NIH HHS U19AI067152
6 · The paper itself

Abstract

introductionSelective IgA deficiency (IgAD; serum IgA concentration of <0.07 g/l) is the most common primary immunodeficiency in Caucasians with an estimated prevalence of 1/600. The frequency of the extended major histocompatibility complex haplotype HLA A1, B8, DR3, DQ2 (the "8.1" haplotype) is increased among patients with IgAD. MATERIALS AND

methodsWe carried out a direct measurement of the relative risk of homozygosity of the 8.1 haplotype for IgA deficiency in a population-based sample of 117 B8, DR3 homozygous individuals. RESULTS AND DISCUSSION: IgA deficiency was found to be present in 2 of 117 (1.7%) of these subjects, a figure that is concordant with estimates of relative risk from large case-control studies in the Swedish population. These data are consistent with a multiplicative model for the 8.1 haplotype contribution to IgA deficiency and contrasts with prior studies, suggesting a much higher risk for 8.1 homozygosity. Using a dense single nucleotide polymorphism marker analysis of the MHC region in HLA B8, DR3, DQ2 homozygous individuals, we did not observe consistent differences between cases (n = 26) and controls (n = 24). Overall, our results do not support the hypothesis that IgA deficiency is associated with a distinct subgroup of 8.1 related haplotypes, but rather indicate that risk is conferred by the common 8.1 haplotype acting in multiplicative manner.

Indexed as

HaplotypesWhite PeopleComputer SimulationDNA Mutational AnalysisGene FrequencyGenetic HeterogeneityGenetics, PopulationHLA-A1 AntigenHLA-B8 AntigenHLA-DR3 AntigenHumansIgA DeficiencyImmunoglobulin APrevalenceRiskSample SizeHLA-A1 AntigenHLA-B8 AntigenHLA-DR3 AntigenImmunoglobulin A

Identifiers

PMID19834793
PMCPMC11292587
OpenAlexW2033616187

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.